PMC:7781431 / 489-839 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"32","span":{"begin":33,"end":43},"obj":"Species"},{"id":"37","span":{"begin":192,"end":198},"obj":"Chemical"},{"id":"38","span":{"begin":216,"end":224},"obj":"Chemical"},{"id":"39","span":{"begin":226,"end":235},"obj":"Chemical"},{"id":"40","span":{"begin":237,"end":245},"obj":"Chemical"},{"id":"44","span":{"begin":69,"end":81},"obj":"Disease"},{"id":"45","span":{"begin":126,"end":135},"obj":"Disease"},{"id":"46","span":{"begin":324,"end":336},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"Tax:2697049"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"MESH:D008055"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:D044045"},{"id":"A44","pred":"tao:has_database_id","subj":"44","obj":"MESH:D007249"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D003643"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"f therapeutic strategies. In the SARS-CoV-2 cytokine storm, systemic inflammation has been associated with severe illness and mortality. Recent studies have demonstrated special pro-resolving lipids mediators (SPMs) lipoxins, resolvins, maresins, and protectins as potential therapeutic options for abnormal viral-triggered inflammation. Pro-resolvin"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":44,"end":58},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"f therapeutic strategies. In the SARS-CoV-2 cytokine storm, systemic inflammation has been associated with severe illness and mortality. Recent studies have demonstrated special pro-resolving lipids mediators (SPMs) lipoxins, resolvins, maresins, and protectins as potential therapeutic options for abnormal viral-triggered inflammation. Pro-resolvin"}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":26,"end":136},"obj":"Sentence"},{"id":"T6","span":{"begin":137,"end":337},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"f therapeutic strategies. In the SARS-CoV-2 cytokine storm, systemic inflammation has been associated with severe illness and mortality. Recent studies have demonstrated special pro-resolving lipids mediators (SPMs) lipoxins, resolvins, maresins, and protectins as potential therapeutic options for abnormal viral-triggered inflammation. Pro-resolvin"}